FDA Inspection 695241 — Allure Labs, LLC

Allure Labs, LLC — FEI 3000204079

The FDA completed an inspection of Allure Labs, LLC on November 22, 2010 in Hayward, CA. The inspection was classified OAI (Official Action Indicated — objectionable conditions were found and regulatory action is recommended). 21 citations were issued during this inspection. Product area: Drugs.

Inspection Details

Classification
Official Action Indicated (OAI) (OAI)
End Date
November 22, 2010
Fiscal Year
2011
Product Type
Drugs
Project Area
Drug Quality Assurance
Location
Hayward, CA (United States)

Citations

IDCFRDescription
110521 CFR 211.22(d)Procedures not in writing, fully followed
111221 CFR 211.25(a)Training--operations, GMPs, written procedures
121321 CFR 211.67(a)Cleaning / Sanitizing / Maintenance
127421 CFR 211.68(a)Calibration/Inspection/Checking not done
139521 CFR 211.103Actual vs. theoretical yields not determined
141121 CFR 211.105(b)Distinctive ID or code not recorded in batch record
145021 CFR 211.113(a)Procedures for non-sterile drug products
149621 CFR 211.122(a)Sampling/testing of labeling/packaging materials
177421 CFR 211.142(a)Quarantine - actual practice
179621 CFR 211.80(d)Identification of Each Lot in Each Shipment
185121 CFR 211.84(e)Rejecting When Specifications Not Met
188321 CFR 211.165(a)Testing and release for distribution
188521 CFR 211.165(b)Microbiological testing
189121 CFR 211.165(f)Failing drug products not rejected
202721 CFR 211.192Investigations of discrepancies, failures
357221 CFR 211.100(b)Procedure Deviations Recorded and Justified
359221 CFR 211.110(c)In-process materials characteristics testing
431521 CFR 211.84(d)(2)Testing Each Component for Conformity with Specs
435121 CFR 211.160(b)(3)Drug products - samples representative, identified properly
440621 CFR 211.194(a)(2)Suitability of testing methods verified
441321 CFR 211.194(a)(8)Second person sign off